AguilarZ., AkitaR.W., FinnR.S.: Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.Oncogene, 18: 6050–6062, 1999.
4.
HerlynD., HerlynM., RossA.: Efficient selection of human tumor growth-inhibiting monoclonal antibodies.J Immunol Methods, 73: 157–167, 1984.
5.
MendelsohnJ.: Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy.Clin. Cancer Res, 3: 2703–2707, 1997.
6.
RiethmüllerG., Schneider-GadickeE., SchmiegelW.: Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes’ C colorectal carcinoma.German Cancer Aid 17-1A Study Group Lancet, 343: 1177–1183, 1994.
7.
ReichertJ.M.: Monoclonal antibodies in the clinic.Nat Biotechnol, 19: 819–822, 2001.
8.
LinnenbachA.J., SengB.A., WuS.Retroposition in a family of carcinoma-associated antigen genes.Mol Cell Biol, 13: 1507–1515, 1993.
9.
AlbertiS., MiottiS., StellaM.: Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2.Hybridoma, 11: 539–535, 1992.
10.
SteinR., BasuA., ChenS.: Specificity and properties of mab RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody.Int J Cancer, 55: 938–946, 1993.
11.
SteinR., BasuA., GoldenbergD.M.: Characterization of cluster 13: the epithelial/carcinoma antigen recognized by MAb RS7.Int J Cancer, 8: 98–102, 1994.
12.
FradetY., Cordon-CardoC., ThomsonT.: Cell-surface antigens of human bladder cancer defined by mouse monoclonal antibodies.Proc Natl Acad Sci USA, 81: 224–228, 1984.
13.
LipinskiM., ParksD.R., RouseR.V.: Human trophoblast cell-surface antigens defined by monoclonal antibodies.Proc. Natl Acad Sci USA, 78: 5147–5150, 1981.
14.
KleinC.E., HartmannB., SchonM.P.: Expression of 38-kD cell-surface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs.J Invest Dermatol, 95: 74–82, 1990.
15.
LitvinovS.V., Van DrielW., Van RhijnC.M.: Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearence of markers for terminal differentiation.Am J Pathol, 148: 865–875, 1996.
BalzarM., Briaire-de BruijnI.H., Rees-BakkerH.A.M.: Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions.Mol Cell Biol, 21: 2570–2580, 2001.
18.
FornaroM., Dell'ArcipreteR., StellaM.: Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas.Int J Cancer, 62: 610–618, 1995.
19.
El-SewedyT., FornaroM., AlbertiS.: Cloning of the mouse Trop2 gene-conservation of a PIP2-binding sequence in the cytoplasmic domain of Trop-2.Int J Cancer, 75: 324–331, 1998.
20.
LinnenbachA.J., WojcierowskiJ., WuS.A.: Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733.Proc Natl Acad Sci USA, 86: 27–31, 1989.
21.
SchönM.P., SchönM., MattesM.J.: Biochemical and immunological characterization of the human carcinoma- associated antigen MH 99/KS 1/4.Int J Cancer, 55: 988–995, 1993.
22.
WurfelJ., RoselM., SeiterS.: Metastasis-association of the rat ortholog of the human epithelial glycoprotein antigen EGP314.Oncogene, 18: 2323–2334, 1999.
23.
BasuA., GoldenbergD.M., SteinR.: The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303.Int J Cancer, 62: 472–479, 1995.
24.
CiccarelliF., AcciaritoA., AlbertiS.: Large and diverse numbers of human diseases with HIKE mutations.Hum Mol Genet, 9: 1001–1007, 2000.
25.
RipaniE., SacchettiA., CordaD.: The human Trop-2 is a tumor-associated calcium signal transducer.Int J Cancer, 76: 671–676, 1998.
26.
CalabreseG., CrescenziC., MorizioE.: Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias Trop-2, M1S1) to human chromosome 1p32 by in situ hybridization.Cytogenet. Cell Genet, 92: 164–165, 2001.
27.
AlbertiS., HerzenbergL.A.: DNA Methylation prevents transfection of genes for specific surface antigenes.Proc Natl Acad Sci USA, 85: 8391–8394, 1988.
28.
AlbertiS., NutiniM., HerzenbergL.A.: DNA methylation prevents the amplification of Trop-1, a tumor associated cell surface antigen gene.Proc Natl Acad Sci USA, 91: 5833–5837, 1994.
29.
MitelmanF.: Recurrent chromosome aberrations in cancer.Mutat Res, 462: 247–253, 2000.
30.
TsujikawaM., KurahashiH., TanakaT.: Identification of the gene responsible for gelatinous drop-like corneal dystrophy.Nat Genet, 21: 420–423, 1999.
31.
RiethmüllerG., Schneider-GädickeE., SchlimokG.: Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes’ C colorectal carcinoma.German Cancer Aid 17-1A Study Group Lancet, 343: 1177–1183, 1994.
32.
MellstedtH., FrodinJ.E., RagnhammarP.: Therapy of colorectal carcinoma with monoclonal antibodies (MAb17-1A) alone and in combination with granulocyte monocyte-colony stimulating factor (GM-CSF).Acta Oncol, 30: 923–931, 1991.
33.
HerlynD., SearsH.F., ErnstC.S.: Initial clinical evaluation of two murine IgG2a monoclonal antibodies for immunotherapy of gastrointestinal carcinoma.Am J Clin Oncol, 14: 371–378, 1991.
34.
McLaughlinP.M.J., HarmsenM.C., DokterW.H.A.: The Epithelial Glycoprotein 2 (EGP-2) Promoter-driven Epithelial-specific Expression of EGP-2 in Transgenic Mice: A New Model to Study Carcinoma-directed Immunotherapy.Cancer Res, 61: 4105–4111, 2001.
35.
CoM.S., QueenC.: Humanized antibodies for therapy.Nature, 351: 501–502, 1991.
36.
GavilondoJ.V., LarrickJ.W.: Antibody engineering at the millennium.Biotechniques, 29: 128–138, 2000.
37.
ReiterY., PastanI.: Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis.Trends Biotechnol, 16: 513–520, 1998.
38.
CremonesiM., FerrariM., ChinolM.: Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.Eur J Nucl Med, 26: 110–120, 1999.
